首页 › 基金 › Defilade Capital Management, L.P. › BDTX
Defilade Capital Management, L.P. 对 BDTX 的持仓历史
BLACK DIAMOND THERAPEUTICS I · 医疗保健
Defilade Capital Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 BDTX(BLACK DIAMOND THERAPEUTICS I)1,674,999 股,市值约 US$3.1M,约占其申报组合的 0.41%,在其申报持仓中市值排名第 38 位。 Defilade Capital Management, L.P. 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Defilade Capital Management, L.P. 对 BDTX 的持仓演变
Defilade Capital Management, L.P. 于 Q2 2026 首次披露 BDTX 持仓:1,674,999 股(约 US$3.1M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 1.67M | $3.10M | 新进 |
关于 BDTX 与 13F 数据
BDTX(BLACK DIAMOND THERAPEUTICS I)属于医疗保健行业。我们追踪的基金中还有 18 只申报持有 BDTX,申报仓位最大的包括:NEA Management Company, LLC (US$8.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Defilade Capital Management, L.P.
常见问题
How long has Defilade Capital Management, L.P. held BDTX?
Defilade Capital Management, L.P. has disclosed BDTX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Defilade Capital Management, L.P.'s current position in BDTX?
As of Q2 2026, Defilade Capital Management, L.P. holds 1.67M shares of BDTX (BLACK DIAMOND THERAPEUTICS I), valued at $3.10M, representing 0.41% of its reported portfolio and ranking #38.
Has Defilade Capital Management, L.P. been buying or selling BDTX?
In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. newly opened its position in BDTX.
Which other funds hold BDTX?
Other major institutional holders of BDTX include NEA Management Company, LLC, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.